Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Advances in Pharmacokinetics and Pharmacodynamics
This book provides a concise overview of recent advances in Pharmacokinetics (PK) and Pharmacodynamics (PD). The pharmacokinetics section covers the state of the art in Physiologically Based Pharmacokinetic (PBPK) modeling (Chapter 1) as well as the assessment of food effect on drug absorption using PBPK modeling (Chapter 2). Chapters 3 and 4 describe the recent development of Physiologically Based Finite Time Pharmacokinetic (PBFTPK) models and their applications to pharmacokinetic data. The pharmacodynamics section focuses on PK/PD modeling. Chapter 5 provides an overview of PK/PD modeling and simulation in clinical practice and studies. Chapter 6 deals with the subject/physiology variability issue encountered in PK/PD studies, while Chapter 7 reviews the influence of clinical pharmacology in the modernization of drug development and regulation. This book is an essential reference for pharmaceutical scientists.
Pharmacology of Infectious Diseases: World Tuberculosis Day 2022
World Tuberculosis (TB) Day takes place on 24th March and is designed to build awareness about the global epidemic of TB as well as the efforts and advances in eliminating the disease. TB is one of the leading causes of death from infectious diseases. The 24th March commemorates that day when Dr. Robert Koch announced that a small group of scientists at the University of Berlin’s Institute had discovered the cause of tuberculosis, the TB bacillus in 1882. This marked a turning point in the story of virulent human infectious diseases. It is in this spirit that Frontiers is launching this Research Topic to coincide with this United Nations (UN) day. This occasion not only offers an opportunity to acknowledge and build awareness of the diseases but also to consider the importance of research in pharmacology and advances in treatment strategies.
Paediatric drug optimization for neglected tropical diseases
Priority-setting is the first step to enable a targeted approach to research and development. Developing a prioritized drug portfolio of the most needed formulations for children is essential to streamline researchers’ and supplier’s efforts and resources around specific dosage forms and formulations that address most urgent needs for children. In general, due to limited financial incentives, few new drugs are being developed for Neglected Tropical Diseases (NTDs). Several NTDs disproportionately affect children compared to adults and, as is the case like for most diseases affecting adults and children, the burden to children is compounded by lack of inclusion of paediatric populations i...
Unreason
UNREASON: Exploring Pseudoscience, Conspiracies, and Extraordinary Claims is a collection of forty-five of the best articles the legendary Skeptical Inquirer magazine has published in the past decade. Featuring articles from writers including Neil deGrasse Tyson on the process of science, Richard Dawkins on the standards of truth, Elizabeth Loftus on memory, Steven Pinker on the notion of progress, and many others covering topics from the politicization of science to the frightening rise of misinformation, each entry in this collection brings scientific examination to bear in order to ferret out the facts and misconceptions behind popular claims. All of the articles within are interesting an...
Writing Double
Although Roland Barthes and Michel Foucault announced the death of the author several decades ago, critics have been slow to abandon the idea of the solitary writer. Bette London maintains that this notion has blinded us to the reality that writing is seldom an individual activity and that it has led us to overlook both the frequency with which women authors have worked together and the significance of their collaborative undertakings as a form of professional activity. In Writing Double, the first full-length treatment of women's literary partnerships, she goes to the heart of issues surrounding authorial identity. What is an author? Which forms of authorship are sanctioned and which forms ...
Drug Discovery for Leishmaniasis
For human health, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Globally, 10 to 12 million people are infected with 1.5 million new cases every year. The development of cheaper new drugs is urgently needed for this neglected disease that is developing resistance to current treatments. Chemotherapy remains the only treatment option for the bulk of patients. However, this is largely unaffordable for most. In the past three years numerous advances in drug discovery have been made for treating this disease by exploiting diverging metabolic pathways between the Leishmania enzymes and their hosts, using nanotechnology to target the immune cell phagolysos...
Drug Discovery for Leishmaniasis
Drug Discovery for Leishmaniasis aims to provide a perspective of the current treatments and their challenges, blended with the emerging strategies and methodologies that will drive new target appraisals and drug developments, as well as addressing the molecular basis of resistance in Leishmania.
Quantitative and Qualitative Determination Technologies of Counterfeit Drugs
Drugs are often counterfeited to reduce manufacture costs, while still marketing it at as an authentic product. Increased incidence of drug counterfeiting is most noticeable in developing countries, which may not have the resources to supply counterfeit detection devices on a large scale. It is important to consider the problems caused and to propose options for controlling and reducing the prevalence of counterfeit medications. Various technologies are needed to identify the chemical properties of a questioned medicinal product, which can then be used to determine its authenticity. This volume focuses on current technological approaches that are able to detect counterfeited pharmaceuticals....
